Journal article

Late-onset ornithine transcarbamylase deficiency: a potentially fatal yet treatable cause of coma.

DC Crosbie, H Sugumar, MA Simpson, SP Walker, HM Dewey, MC Reade

Critical Care and Resuscitation Journal of the Australasian Academy of Critical Care Medicine | AUSTRALASIAN MED PUBL CO LTD | Published : 2009

Abstract

Hyperammonaemia due to ornithine transcarbamylase (OTC) deficiency is a well-described cause of coma in neonates. Rarely, adults with this disorder may also present with coma. Here we describe the first reported case, to our knowledge, in a pregnant woman. She was successfully treated with metabolic therapy and, contrary to usual paediatric practice, renal replacement therapy. We review the biochemistry of OTC deficiency and other urea cycle disorders, and discuss the physiological rationale and evidence base for treatment of this condition. We highlight the need to consider hyperammonaemia in the differential diagnosis of coma.

University of Melbourne Researchers